Abstract Cytokine storm (CS) is a severe systemic inflammatory syndrome characterized by the excessive activation of immune cells and a significant increase in circulating levels of cytokines. This pathological process..
Read More
Abstract Objectives Approximately 8 - 10 % of COVID-19 patients present with a serious clinical course and need for hospitalization, 8% of hospitalized patients need ICU-treatment. Currently, no causal therapy..
Read More
This case reports on a 59-year-old SARS-CoV-2 positive male patient with a history of chronic lymphocytic leukemia (CLL), who was transferred from an external hospital to the intensive care unit..
Read More
Abstract This case reports on a 58-year-old male patient with a medical history of ulcerative colitis, who was admitted to the Emergency Department with a body temperature up to 40°C,..
Read More
This case reports on a previously fit and well 45-year-old male patient who was transferred from an ex- ternal hospital to the University Hospital St. Pölten already intubated and ventilated...
Read More
Limited treatment options are currently available for critically-ill COVID-19 ICU patients who may experience mortality rates up to 50%. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/02/CytoSorb-Therapy-Manage-cytokine-storm-in-patients-with-COVID-19_compressed.pdf" title="CytoSorb Therapy Manage cytokine storm in patients with..
Read More